Clonogenic Assays Are of Limited Value in Discriminating Patients with Myelodysplastic Syndrome and Patients with Megaloblastic Anemia

Publisher： Karger

E-ISSN： 1421-9662|127|2|118-118

ISSN： 0001-5792

Source： Acta Haematologica, Vol.127, Iss.2, 2012-01, pp. : 118-118

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Prevalence and Survival of Myelodysplastic Syndrome of the Refractory Anemia Type in Hospitalized Cognitively Different Geriatric Patients

Gerontology, Vol. 46, Iss. 6, 2000-10 ,pp. : 323-327

Karger

Access to resources Recommend Favorite

Deferasirox improves hematologic and hepatic function with effective reduction of serum ferritin and liver iron concentration in transfusional iron overload patients with myelodysplastic syndrome or aplastic anemia

TRANSFUSION, Vol. 54, Iss. 6, 2014-06 ,pp. : 1542-1551

John Wiley & Sons Inc

Access to resources Recommend Favorite

Molecular Study of Proteinuria in Patients Treated with B₁₂ Supplements: Do Not Forget Megaloblastic Anemia Type 1

Nephron Clin Pract, Vol. 118, Iss. 2, 2010-12 ,pp. : c67-c71

Karger

Access to resources Recommend Favorite

Increased Serum CA-15.3 Levels in Patients with Megaloblastic Anemia due to Vitamin B₁₂ Deficiency

Oncology, Vol. 67, Iss. 5-6, 2005-02 ,pp. : 359-367

Karger

Access to resources Recommend Favorite

Efficacy and safety of deferasirox estimated by serum ferritin and labile plasma iron levels in patients with aplastic anemia, myelodysplastic syndrome, or acute myeloid leukemia with transfusional iron overload

TRANSFUSION, Vol. 55, Iss. 7, 2015-07 ,pp. : 1613-1620

John Wiley & Sons Inc

Access to resources Recommend Favorite